Previous Page  8 / 41 Next Page
Information
Show Menu
Previous Page 8 / 41 Next Page
Page Background

Page 52

Notes:

conferenceseries

.com

Volume 5, Issue 5 (Suppl)

Nat Prod Chem Res

ISSN: 2329-6836 NPCR, an open access journal

Pharmacognosy 2017

July 24-25, 2017

July 24-25, 2017 Melbourne, Australia

5

th

International Conference and Exhibition on

Pharmacognosy, Phytochemistry

& Natural Products

Dehydroandrographolide inhibits human oral cancer metastasis by transcriptionally repressing MMP-2

Shun-Fa Yang and Ming-Ju Hsieh

Chung Shan Medical University, Taiwan

O

ral cancer is one of the most common cancers worldwide and metastasis is recognized as a major factor causing its low

survival rate. It is a critical research objective to inhibit the metastasis progress and improve the survival rate for oral cancer.

Dehydroandrographolide is the principal component of

Andrographis paniculata

(Burm.f.) Nees and is the main contributors to its

therapeutic properties. However, the molecular mechanism underlying the anticancer effect induced by dehydroandrographolide

remainsunclear.Inthisstudy,weinvestigatedtheeffectofdehydroandrographolideonSCC-9oralcancercellsandexaminedthepotential

inhibitory mechanisms involved. The results indicated that dehydroandrographolide attenuated the migration and invasion abilities

of SCC-9 cells by reducing the activity and protein expression of matrix metalloproteinases-2 (MMP-2). Dehydroandrographolide

inhibited the phosphorylation of ERK1/2, p38 and JNK 1/2 in SCC-9 cells. According to the mRNA levels detected using real-time

PCR, dehydroandrographolide inhibited MMP-2 expression in SCC-9 cells. In addition, dehydroandrographolide administration

effectively suppressed MMP-2 expression and tumor metastases in the oral carcinoma xenograft mouse model

in vivo

. These data

indicate that dehydroandrographolide could be a potent therapeutic agent for the prevention and treatment of oral cancer and a

prominent plant source for anticancer research in the future.

Biography

Shun-Fa Yang is a Professor of Institute of Medicine, Chung Shan Medical University, Taiwan. He has received his PhD degree in Molecular Biology. In particular,

his researches have been focused on pharmacology, head and neck cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in

cancer.

ysf@csmu.edu.tw

Shun-Fa Yang et al., Nat Prod Chem Res 2017, 5:5 (Suppl)

DOI: 10.4172/2329-6836-C1-017